AI is changing cancer treatment — and a new breakthrough shows just how far we've come
AI-generated summary Researchers are using artificial intelligence to understand cancer at a detailed level and develop personalized treatments based on a patient's unique genetic tumor makeup. In a Phase 3 trial, an experimental personalized melanoma vaccine developed by Moderna and Merck combined with Keytruda reduced recurrence or death risk by 42% compared with Keytruda alone.